Company intelligence / Profile preview

Veredus Laboratories

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Veredus Laboratories develops, manufactures, and distributes molecular diagnostics for rapid, multiplexed pathogen detection, with products deployed in Singapore’s public health infrastructure during outbreaks, including COVID-19.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic deviceDiagnostic assayMolecular diagnosticsLab-on-a-chip
Industry: Molecular Diagnostics

Partnerships

STMicroelectronics (development of rapid diagnostic kits based on lab-on-a-chip technology)A*STAR and National University of Singapore (technology licensing)

Beyond the preview

Go deeper on Veredus Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veredus Laboratories.

Explore the full profile